Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
(S)-[18F]FBFP is a fluorine-18 labeled radiopharmaceutical that serves as a positron emission tomography (PET) tracer for the sigma-1 receptor (σ1R). The sigma-1 receptor is a molecular chaperone located in the endoplasmic reticulum that modulates various cellular processes, including calcium signaling and protein folding. It is highly expressed in the central nervous system and is implicated in the pathophysiology of neurodegenerative diseases, such as Alzheimer's and Parkinson's, as well as psychiatric disorders like major depression. (S)-[18F]FBFP is the S-enantiomer of a piperazine derivative, chosen for its high affinity and selectivity for σ1R over the sigma-2 receptor. In clinical research, it is used to non-invasively map and quantify σ1R density in the human brain, providing insights into disease mechanisms and facilitating the development of σ1R-targeted therapies by measuring receptor occupancy.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on (S)-[18F]FBFP.